ArticleMycotoxin research2025
Optimization and validation of a targeted high-throughput UHPLC-MS/MS method for the analysis of multiple mycotoxins in chicken serum, egg yolk and white.
Article in Mycotoxin research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- In-House Fabricated One-Step SPE Cartridge with HPLC-MS/MS for Fast and Accurate Determination of Multi-Class Contaminants in Eggs.Foods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mycotoxins, produced by fungi, contaminate animal feed and subsequently enter food products like eggs, posing significant health risks. This study aimed to optimize and validate a sensitive, cost-efficient, high-throughput UHPLC-MS/MS method for the qualitative analysis of 38 mycotoxins, and the quantification of 30, 29 and 29 regulated and emerging mycotoxins in chicken serum, egg yolk and egg white, respectively. Sample preparation involved liquid extraction with 0.1% formic acid in acetonitrile, followed by protein and phospholipid removal using Oasis
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.